Erudio Healtherudio.com
Drug
Tiragolumab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying tiragolumab: SKYSCRAPER-03. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| SKYSCRAPER-03 NCT04513925 · Hoffmann-La Roche | locally advanced, unresectable stage III NSCLC | Phase 3 | 122 | 39 | Focused | Oct 31, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| SKYSCRAPER-02 NCT04256421 · Hoffmann-La Roche DeepView → | untreated extensive-stage small cell lung cancer | Phase 3 | Deep | View | |||
| SKYSCRAPER-01 NCT04294810 · Hoffmann-La Roche DeepView → | Not given | Phase 3 | Deep | View | |||
| CITYSCAPE NCT03563716 · Genentech, Inc. DeepView → | first-line PD-L1-selected non-small-cell lung cancer | Phase 2 | Deep | View | |||
| MORPHEUS-UC NCT03869190 · Hoffmann-La Roche StandardView → | urothelial carcinoma | Phase 1/Phase 2 | Standard | View | |||
| SKYSCRAPER-05 NCT04832854 · Hoffmann-La Roche FocusedView → | previously untreated locally advanced resectable stage II–IIIB NSCLC | Phase 2 | Focused | View | |||
| NeoACTIVATE NCT03554083 · Mayo Clinic FocusedView → | high-risk stage III melanoma | Phase 2 | Focused | View | |||
| SKYSCRAPER-02C NCT04665856 · Hoffmann-La Roche FocusedView → | untreated extensive-stage small cell lung cancer | Phase 3 | Focused | View | |||
| NCT04958811 NCT04958811 · Georgetown University FocusedView → | previously-treated advanced non-squamous NSCLC | Phase 2 | Focused | View | |||